| Mepha Pharma AG - Lisinopril-Mepha 5, Tabletten | | 56777 | | 01 | | Lisinopril-Mepha 5 | | Tabletten | | C09AA03 | | Lisinopril | | 26.08.2005 | | |
| | Composition | | lisinoprilum 5 mg ut lisinoprilum dihydricum, mannitolum, calcii hydrogenophosphas dihydricus, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 1.00 mg, magnesii stearas, pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Lisinopril | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Lisinopril | 5 mg |
| | | | Inactive agents |
|---|
| | | Calcium Hydrogen Phosphate Dihydrate | | | | | | Mannitol | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 30 Tablet(s) | 2.42 | 11.85 | B | SL | No | | 004 | 100 Tablet(s) | 6.20 | 16.00 | B | SL | No |
|
|
